Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Food Effect of ND-003 Tablets in Healthy Adult Volunteers

NCT06360874 is registered in ClinicalTrials.gov with Shenzhen NewDEL Biotech, Co., Ltd as lead sponsor.

NCT NCT06360874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Food Effect of ND-003 Tablets in Healthy Adult Volunteers
Lead sponsor
Shenzhen NewDEL Biotech, Co., Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
May 9, 2024
Completion date
February 28, 2025
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy